Epigenetic therapies are offering a more targeted way to treat some lymphomas by changing how genes are turned on or off ...
A team from the University of Barcelona has designed and validated in animal models an innovative compound with a pioneering ...
Great Novel Therapeutics Biotech & Medicals Corporation (GNTbm) (stock code: 7427) announced that its independently developed novel epigenetic immunoactivator GNTbm-38, with global rights for cancer ...
Researchers discovered that a small region of the PRC2 protein complex acts as a functional switch controlling gene silencing. Removing this domain stopped cancer cell growth, highlighting a potential ...
Copenhagen, March, 2025 - The University of Copenhagen is excited to announce TruDiagnostic, a leader in epigenetic testing, will present its latest advancements at the 12th Aging Research and Drug ...
A team from the University of Barcelona has designed and validated in animal models an innovative compound with a pioneering mechanism of action for ...
In vitro findings reveal Telomir-1’s dual action: targeting DNA methylation switches and cutting into the Wnt “fuel line” that drives cancer growth. MIAMI, FLORIDA / ACCESS Newswire / August 28, 2025 ...
During the process of metastasis, tumor cells inevitably encounter the stimulation of various oxidative stressors, resulting in the fluctuation of intracellular reactive oxygen species (ROS) levels.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results